North America PCR Technologies Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America PCR Technologies Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America PCR Technologies Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Adoption of PCR Techniques

5.2 Market Opportunities

5.2.1 Advancements in PCR Technologies

5.3 Future Trends

5.3.1 Rising Investments and Funds Availability for PCR Technologies

5.4 Impact of Drivers and Restraints

6. North America PCR Technologies Market Regional Analysis

6.1 North America PCR Technologies Market Overview

6.2 North America PCR Technologies Market Revenue 2020-2030 (US$ Million)

6.3 North America PCR Technologies Market Forecast Analysis

7. North America PCR Technologies Market Analysis – by Technology

7.1 Real-Time PCR

7.1.1 Overview
7.1.2 Real-Time PCR: North America PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Conventional PCR

7.2.1 Overview
7.2.2 Conventional PCR: North America PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Reverse Transcription PCR

7.3.1 Overview
7.3.2 Reverse Transcription PCR: North America PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Digital PCR

7.4.1 Overview
7.4.2 Digital PCR: North America PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Multiplex RT PCR

7.5.1 Overview
7.5.2 Multiplex RT PCR: North America PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Hot Start PCR

7.6.1 Overview
7.6.2 Hot Start PCR: North America PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)

8. North America PCR Technologies Market Analysis – by Offerings

8.1 Reagents & Consumables

8.1.1 Overview
8.1.2 Reagents & Consumables: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Instruments

8.2.1 Overview
8.2.2 Instruments: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Software & Services

8.3.1 Overview
8.3.2 Software & Services: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

9. North America PCR Technologies Market Analysis – by End User

9.1 Hospitals & Diagnostic Centers

9.1.1 Overview
9.1.2 Software & Services: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Academia & Research Institutes

9.2.1 Overview
9.2.2 Software & Services: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

9.3 Pharmaceutical & Biotechnology Companies

9.3.1 Overview
9.3.2 Software & Services: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

10. North America PCR Technologies Market – North America Analysis

10.1 North America

10.1.1 North America PCR Technologies Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America PCR Technologies Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America PCR Technologies Market Breakdown, by Technology
10.1.1.1.2 US: North America PCR Technologies Market Breakdown, by Offerings
10.1.1.1.3 US: North America PCR Technologies Market Breakdown, by End User

10.1.1.2 Canada: North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America PCR Technologies Market Breakdown, by Technology
10.1.1.2.2 Canada: North America PCR Technologies Market Breakdown, by Offerings
10.1.1.2.3 Canada: North America PCR Technologies Market Breakdown, by End User

10.1.1.3 Mexico : North America PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America PCR Technologies Market Breakdown, by Technology
10.1.1.3.2 Mexico : North America PCR Technologies Market Breakdown, by Offerings
10.1.1.3.3 Mexico : North America PCR Technologies Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America PCR Technologies Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Promega Corp

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 QIAGEN NV

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 bioMerieux SA

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Hoffmann-La Roche Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Bio-Rad Laboratories Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Becton Dickinson and Co

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Atila Biosystems Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Takara Bio Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Standard BioTools Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 Agilent Technologies Inc

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

13.12 Visby Medical Inc

13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments

13.13 Ellume Ltd

13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments

14. Appendix

14.1 About Business Market Insights